Biocatalysts Ltd expands its Manufacturing Capabilities with Large-Scale Freeze Drying
Biocatalysts Ltd, a BRAIN Biotech Group company, has expanded its production capacity at its Cardiff manufacturing site with the addition of a large-scale freeze-drying facility. With his new facility the leading expert in the discovery, development and fermentation of enzymes for the food, beverage and life sciences industries, will enable greater customization and ensure flexibility and precision in the formulation of enzymes.
Freeze-drying is widely used in life sciences and biotechnology to preserve products and protect them from losing their functional and biological activity. To meet customers' stringent requirements and ensure optimal product quality, the new industrial-scale freeze-drying capacity was designed to align with both kosher and halal requirements and compliance with ISO9001:2015 and FSSC22000 quality and safety standards.
The current expansion fits into Biocatalysts’ multi-year manufacturing expansion program to accommodate increased demand for fermentation capacity and enzyme products. Other expansions have included investments in fermentation vessels, downstream processing, and formulation capacity.
This latest investment in large-scale freeze-drying onsite, enables greater customisation of solutions, tailoring enzyme formulations specific to customer and industry needs to offer flexibility and precision in enzyme formulation.
“Freeze drying is a very gentle process for drying specialty products that preserves the valuable functionality of the dried product. Our new, specially developed freeze dryer with its large capacity enables our products to be dried extremely efficiently. The dryer is designed to offer maximum flexibility. This enables it to meet the requirements of a wide range of customized dried products. This is an extremely valuable addition to our production capabilities at Biocatalysts Ltd”